v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Aug. 02, 2026
Aug. 03, 2025
Cash flows from operating activities:    
Net income (loss) $ 5,981 $ (231)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation 911 1,111
Non-cash inventory charge (credit) 745 (67)
Amortization 29 95
Stock-based compensation 150 156
Deferred income taxes (843) 309
Gain on sale of equipment   (9)
Realized gain on sale of investments (rabbi trust) (9)  
Non-cash restructuring credit   (3,664)
Foreign currency exchange loss 360 122
Changes in assets and liabilities:    
Accounts receivable 113 3,482
Inventories 4,542 (683)
Other current assets (1,485) 212
Other assets 13 13
Accounts payable – trade (3,400) (3,126)
Deferred revenue (78) 63
Accrued restructuring (37) (506)
Accrued expenses and deferred compensation 724 1,016
Income taxes 386 1,012
Net cash provided by (used in) operating activities 8,102 (695)
Cash flows from investing activities:    
Capital expenditures (314) (179)
Proceeds from the sale of property, plant, and equipment   966
Proceeds from notes receivable 90 120
Proceeds from the sale of investments (rabbi trust) 313 237
Purchase of investments (rabbi trust) (91) (158)
Net cash (used in) provided by investing activities (2) 986
Cash flows from financing activities:    
Proceeds from lines credit 6,122 5,886
Payments on lines of credit (12,085) (552)
Payment of debt issuance costs   (120)
Common stock surrendered for withholding taxes payable (103) (60)
Net cash (used in) provided by financing activities (6,066) 5,154
Effect of foreign currency exchange rate changes on cash and cash equivalents (72) 20
Increase in cash and cash equivalents 1,962 5,465
Cash and cash equivalents at beginning of year 8,273 5,629
Cash and cash equivalents at end of period $ 10,235 $ 11,094